Vertex Pharmaceuticals (VRTX) on Tuesday announced that the European Commission has granted approval for Alyftrek for the ...

Vertex Pharmaceuticals said on Tuesday its next-generation cystic fibrosis treatment has won European Union approval for a ...

Sickle cell is now the fastest growing genetic condition in the United Kingdom and can cause organ damage and strokes.

When faced with the myriad diseases and equally numerous targets for potential drugs the company could pursue, Kewalramani ...